DK0428105T3 - Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein - Google Patents

Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein

Info

Publication number
DK0428105T3
DK0428105T3 DK90121632.5T DK90121632T DK0428105T3 DK 0428105 T3 DK0428105 T3 DK 0428105T3 DK 90121632 T DK90121632 T DK 90121632T DK 0428105 T3 DK0428105 T3 DK 0428105T3
Authority
DK
Denmark
Prior art keywords
ones
infections
isoquinolyloxazol
quinolyl
glycoprotein
Prior art date
Application number
DK90121632.5T
Other languages
English (en)
Inventor
Sai P Sunkara
Winton D Jones
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of DK0428105T3 publication Critical patent/DK0428105T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90121632.5T 1989-11-13 1990-11-12 Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein DK0428105T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43531889A 1989-11-13 1989-11-13

Publications (1)

Publication Number Publication Date
DK0428105T3 true DK0428105T3 (da) 1994-02-28

Family

ID=23727911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90121632.5T DK0428105T3 (da) 1989-11-13 1990-11-12 Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein

Country Status (11)

Country Link
EP (1) EP0428105B1 (da)
JP (1) JP2927930B2 (da)
KR (1) KR0162639B1 (da)
AT (1) ATE100318T1 (da)
AU (1) AU630249B2 (da)
DE (1) DE69006187T2 (da)
DK (1) DK0428105T3 (da)
ES (1) ES2062266T3 (da)
IE (1) IE63851B1 (da)
PH (1) PH27309A (da)
ZA (1) ZA908933B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Also Published As

Publication number Publication date
JP2927930B2 (ja) 1999-07-28
DE69006187D1 (de) 1994-03-03
AU6592990A (en) 1991-05-16
KR910009260A (ko) 1991-06-28
KR0162639B1 (ko) 1998-12-01
IE63851B1 (en) 1995-06-14
DE69006187T2 (de) 1994-05-05
EP0428105A2 (en) 1991-05-22
IE904079A1 (en) 1991-05-22
PH27309A (en) 1993-05-28
AU630249B2 (en) 1992-10-22
ATE100318T1 (de) 1994-02-15
ES2062266T3 (es) 1994-12-16
EP0428105B1 (en) 1994-01-19
JPH03173886A (ja) 1991-07-29
EP0428105A3 (en) 1991-12-11
ZA908933B (en) 1991-08-28

Similar Documents

Publication Publication Date Title
EA200201279A1 (ru) Способы и композиции для лечения вирусного гепатита c
EA200201263A1 (ru) СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
EA199901031A1 (ru) Производные бензимидазола
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
ES2051641B1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
DK602988A (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
MY151199A (en) Substituted diphenyl heterocycles useful for treating hcv infection
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
GR3034279T3 (en) Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
BR0008135A (pt) Composto, métodos para tratar uma infecção por vìrus em um ser humano e para tratar uma infecção pelo vìrus da hepatite b em um ser humano, composição farmacêutica, uso de um composto, método para liberar um composto, pacote para paciente, processo para a preparação de um composto
GR900100048A (el) Αντιμετώπιση ασθενειών σχετικών με μολύνσεις HΙV.
ES2123156T3 (es) Compuestos y procedimientos de inhibicion de hiv y virus semejantes.
DK1053012T3 (da) Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DK0428105T3 (da) Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
DK0531341T3 (da) Anvendelse af leukoregulin til behandling af dyr, der er inficeret med et kappevirus
DK384387D0 (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE69231465D1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
FI943295A (fi) Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )